BELLETTI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.998
EU - Europa 1.715
AS - Asia 1.435
AF - Africa 90
OC - Oceania 70
SA - Sud America 47
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.357
Nazione #
US - Stati Uniti d'America 2.854
CN - Cina 597
IT - Italia 535
IN - India 230
DE - Germania 217
GB - Regno Unito 133
FR - Francia 112
CZ - Repubblica Ceca 108
IR - Iran 103
CA - Canada 102
RU - Federazione Russa 82
IE - Irlanda 79
JP - Giappone 76
ES - Italia 75
AU - Australia 65
KR - Corea 65
ID - Indonesia 61
NL - Olanda 57
TR - Turchia 52
SE - Svezia 47
UA - Ucraina 45
HK - Hong Kong 36
RO - Romania 35
PL - Polonia 34
SG - Singapore 32
IL - Israele 31
MX - Messico 30
ZA - Sudafrica 29
NG - Nigeria 27
EG - Egitto 22
CH - Svizzera 21
PK - Pakistan 21
TW - Taiwan 21
FI - Finlandia 19
BR - Brasile 18
MY - Malesia 18
VN - Vietnam 16
AE - Emirati Arabi Uniti 14
CL - Cile 14
AT - Austria 13
PT - Portogallo 13
BE - Belgio 12
SA - Arabia Saudita 12
TH - Thailandia 12
GR - Grecia 10
HR - Croazia 10
HU - Ungheria 9
IQ - Iraq 9
NO - Norvegia 9
RS - Serbia 9
LT - Lituania 8
DK - Danimarca 7
PH - Filippine 7
BD - Bangladesh 6
PR - Porto Rico 6
AR - Argentina 5
JO - Giordania 5
NZ - Nuova Zelanda 5
SD - Sudan 5
CU - Cuba 4
EE - Estonia 4
DZ - Algeria 3
KZ - Kazakistan 3
MO - Macao, regione amministrativa speciale della Cina 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EU - Europa 2
LU - Lussemburgo 2
MD - Moldavia 2
PE - Perù 2
BA - Bosnia-Erzegovina 1
CO - Colombia 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NP - Nepal 1
SN - Senegal 1
TN - Tunisia 1
Totale 6.357
Città #
Fairfield 362
Houston 261
Woodbridge 240
Ashburn 207
Seattle 184
Cambridge 151
Wilmington 143
Beijing 141
Modena 137
Ann Arbor 110
Buffalo 101
Santa Cruz 98
Dublin 51
Shanghai 49
Wuhan 46
San Diego 35
Rome 34
Nanjing 33
Stockholm 33
Milan 31
Council Bluffs 27
Chengdu 26
Chicago 26
Mountain View 26
Boardman 24
Guangzhou 24
Hangzhou 24
Los Angeles 24
Barcelona 21
Bengaluru 21
Jakarta 21
Tokyo 21
Las Vegas 20
Delhi 19
Limerick 19
Central 18
Ottawa 18
Seoul 18
Toronto 18
Hyderabad 17
Jerusalem 17
Québec 17
Florence 16
London 16
Padova 16
Shenyang 16
Helsinki 15
Singapore 15
Brno 14
Melbourne 13
Phoenix 13
Silver Spring 13
Tianjin 13
Lake Forest 12
Madrid 12
Prague 12
Taipei 12
Trieste 12
Bologna 11
Cairo 11
Columbus 11
Downers Grove 11
Mumbai 11
Munich 11
New York 11
Paris 11
San Jose 11
University Park 11
Chapel Hill 10
Clearwater 10
Henderson 10
Kuala Lumpur 10
Ahmedabad 9
Bangalore 9
Dearborn 9
Des Moines 9
Lexington 9
Montréal 9
Muizenberg 9
San Francisco 9
Wageningen 9
Warsaw 9
Chennai 8
Chongqing 8
College Station 8
Dong Ket 8
Istanbul 8
Kolkata 8
Norwalk 8
Nutley 8
Patiala 8
Tehran 8
Vellore 8
Boston 7
Brisbane 7
Dallas 7
Duncan 7
Durham 7
Gurgaon 7
Hamburg 7
Totale 3.510
Nome #
Protein corona and nanoparticles: How can we investigate on?, file e31e124c-78c5-987f-e053-3705fe0a095a 1.098
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates, file e31e124c-cee9-987f-e053-3705fe0a095a 879
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art, file e31e124d-13a1-987f-e053-3705fe0a095a 829
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin, file e31e124b-eba1-987f-e053-3705fe0a095a 699
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders, file e31e124d-2485-987f-e053-3705fe0a095a 459
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study, file e31e124a-ab87-987f-e053-3705fe0a095a 391
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery, file e31e124d-11fc-987f-e053-3705fe0a095a 366
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system, file e31e124c-7852-987f-e053-3705fe0a095a 296
Nanoparticle transport across the blood brain barrier, file e31e124b-fd98-987f-e053-3705fe0a095a 254
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice, file e31e124b-2850-987f-e053-3705fe0a095a 211
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders, file e31e124b-c7b2-987f-e053-3705fe0a095a 204
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles, file e31e124b-2afe-987f-e053-3705fe0a095a 184
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity, file e31e124b-e9b6-987f-e053-3705fe0a095a 175
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?, file e31e124b-f096-987f-e053-3705fe0a095a 168
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-fe37-987f-e053-3705fe0a095a 100
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e1250-aac7-987f-e053-3705fe0a095a 56
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles, file e31e124c-47de-987f-e053-3705fe0a095a 39
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124d-a1f5-987f-e053-3705fe0a095a 35
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles, file e31e124a-a629-987f-e053-3705fe0a095a 22
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes, file e31e124a-b003-987f-e053-3705fe0a095a 13
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE, file e31e124a-af12-987f-e053-3705fe0a095a 9
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release, file e31e124a-a708-987f-e053-3705fe0a095a 7
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e124b-3178-987f-e053-3705fe0a095a 6
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine, file e31e124a-b178-987f-e053-3705fe0a095a 5
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments, file e31e124b-3144-987f-e053-3705fe0a095a 5
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation, file e31e124a-a570-987f-e053-3705fe0a095a 4
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents., file e31e124a-a619-987f-e053-3705fe0a095a 4
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma, file e31e124a-aa8a-987f-e053-3705fe0a095a 4
Sialic Acid as a potential approach for the protection and targeting of nanocarriers, file e31e124a-af06-987f-e053-3705fe0a095a 4
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution, file e31e124a-a50d-987f-e053-3705fe0a095a 3
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?, file e31e124b-f655-987f-e053-3705fe0a095a 3
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach, file e31e124c-e424-987f-e053-3705fe0a095a 3
Protein corona and nanoparticles: How can we investigate on?, file e31e124f-e216-987f-e053-3705fe0a095a 3
Nanomedicine: the future for advancing medicine and neuroscience, file e31e124a-add7-987f-e053-3705fe0a095a 2
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury, file e31e124b-29f0-987f-e053-3705fe0a095a 2
Nanotechnology and Alzheimer’s disease: What has been done and what to do’, file e31e124b-2ba1-987f-e053-3705fe0a095a 2
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124b-30fd-987f-e053-3705fe0a095a 2
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system, file e31e124b-3103-987f-e053-3705fe0a095a 2
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-e9bc-987f-e053-3705fe0a095a 2
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws, file e31e124a-a317-987f-e053-3705fe0a095a 1
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study, file e31e124a-aa89-987f-e053-3705fe0a095a 1
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles, file e31e124b-0b5a-987f-e053-3705fe0a095a 1
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma, file e31e124b-29ee-987f-e053-3705fe0a095a 1
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo, file e31e124b-3140-987f-e053-3705fe0a095a 1
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury, file e31e124b-3149-987f-e053-3705fe0a095a 1
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity, file e31e124b-e820-987f-e053-3705fe0a095a 1
Functionalization of liposomes: microscopical methods for preformulative screening, file e31e124b-fd5f-987f-e053-3705fe0a095a 1
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates, file e31e124f-646e-987f-e053-3705fe0a095a 1
Totale 6.559
Categoria #
all - tutte 11.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019204 0 0 0 0 0 0 0 0 0 0 107 97
2019/20201.080 78 45 49 86 86 138 135 97 113 108 85 60
2020/20211.464 80 116 106 87 138 132 87 132 91 248 163 84
2021/20221.411 96 65 157 207 144 81 101 98 110 99 153 100
2022/20231.175 59 60 156 106 129 86 80 74 99 104 141 81
2023/2024505 90 79 85 29 37 30 33 33 26 29 34 0
Totale 6.559